GT Biopharma Reports Full Year 2025 Financial Results

Weekly Voice editorial staff
0 Min Read

Phase 1 trial evaluating GTB-3650 TriKE® continues to actively enroll, with the next update anticipated in Q3 2026 following completion of enrollment in dose Cohort 5

- Advertisement -
Share This Article